Status: current, Defined. Date: 30-Sep 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4460821000168110 | Piperacillin/Tazobactam 4 g/0.5 g (Kabi) (piperacillin 4 g + tazobactam 500 mg) powder for injection, 1 x 4.5 g vial (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4460831000168113 | Piperacillin/Tazobactam 4 g/0.5 g (Kabi) powder for injection, 4.5 g vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Piperacillin/Tazobactam 4 g/0.5 g (Kabi) powder for injection, 4.5 g vial | Is a | Piperacillin/Tazobactam 4 g/0.5 g (Kabi) powder for injection, 4.5 g vial | true | Inferred relationship | Some | ||
| Piperacillin/Tazobactam 4 g/0.5 g (Kabi) powder for injection, 4.5 g vial | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Piperacillin/Tazobactam 4 g/0.5 g (Kabi) powder for injection, 4.5 g vial | has container type | vial | true | Inferred relationship | Some | ||
| Piperacillin/Tazobactam 4 g/0.5 g (Kabi) powder for injection, 4.5 g vial | has TP | Piperacillin/Tazobactam 4 g/0.5 g (Kabi) | true | Inferred relationship | Some | ||
| Piperacillin/Tazobactam 4 g/0.5 g (Kabi) powder for injection, 4.5 g vial | has TPUU | Piperacillin/Tazobactam 4 g/0.5 g (Kabi) powder for injection, 4.5 g vial | true | Inferred relationship | Some | 405348670 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR